Avinger Inc. (AVGR)
0.47
-0.13 (-21.40%)
At close: Feb 14, 2025, 3:59 PM
-21.40% (1D)
| Bid | 0.57 |
| Market Cap | 1.52M |
| Revenue (ttm) | 10.44M |
| Net Income (ttm) | -26.75M |
| EPS (ttm) | -8.76 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -0.47 |
| Analyst | Buy |
| Ask | n/a |
| Volume | 2,592,021 |
| Avg. Volume (20D) | 3,231,001 |
| Open | 0.56 |
| Previous Close | 0.60 |
| Day's Range | 0.46 - 0.61 |
| 52-Week Range | 0.36 - 4.37 |
| Beta | 1.09 |
About AVGR
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment por...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Jan 30, 2015
Employees 68
Stock Exchange NASDAQ
Ticker Symbol AVGR
Website https://avinger.com
Analyst Forecast
According to 1 analyst ratings, the average rating for AVGR stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 954.85% from the latest price.
Stock ForecastsNext Earnings Release
Avinger Inc. is scheduled to release its earnings on Mar 19, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
Avinger shares are trading higher after the compan...
Unlock content with
Pro Subscription
3 months ago
Avinger shares are trading higher after the company announced it has received a Notice of Allowance for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."
